Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Trump cancels Putin meeting, says "didn't feel right"
Al Mayadeen's correspondent in Caracas: The United States attacks another alleged drug-trafficking ship off the coast of Colombia in the Pacific Ocean
Palestinian official urges world to force 'Israel' to comply with ICJ ruling: AFP
Israeli media says Knesset approved bill to annex in West Bank in preliminary reading
Kremlin: As part of strategic nuclear force exercise, Cruiser Bryansk launched Sineva ballistic missile from Barents Sea.
Kremlin: Yars Intercontinental Ballistic Missile launched from Plesetsk Cosmodrome at Kura test site in Kamchatka.
Kremlin: Strategic nuclear forces exercise took place under Putin's leadership.
Lebanese MP Imad Al-Hout, following his meeting with the Grand Mufti of the Republic: Lebanon is the last country to move toward peace and normalization [with "Israel"]
Al Mayadeen's correspondent in South Lebanon: One martyr reported in Israeli drone strike targeting motorcycle in Ain Qana.
Israeli media: Sirens sound in Nahal Oz settlement in Gaza Envelope.

FDA approves first postpartum depression pill in the US

  • By Al Mayadeen English
  • Source: News websites
  • 6 Aug 2023 22:14
3 Min Read

The FDA stated on Friday that the medication, to be offered under the trade name Zurzuvae, has been authorized as a once-daily tablet to be taken for 14 days.

  • x
  • FDA approves first postpartum depression pill in the US
    Postpartum depression affects 1 in 7 new mothers after childbirth. (AP)

Zuranolone has been approved by the US Food and Drug Administration to treat postpartum depression, the first FDA-approved oral pill in the US for the condition.

Postpartum depression is a serious mental condition that develops in nearly 1 in 7 new mothers after childbirth.

The FDA stated on Friday that the medication, to be offered under the trade name Zurzuvae, has been authorized as a once-daily tablet to be taken for 14 days.

According to Dr. Tiffany R. Farchione, director of the Division of Psychiatry in the FDA’s Center for Drug Evaluation and Research program, access to the drug will be beneficial for many women "coping with extreme, and sometimes life-threatening, feelings.” 

Read more: Medical experts say depression to become largest global health crisis

Suicidal thoughts may occur in women suffering from severe postpartum depression, and maternal suicide accounts for around 20% of all postpartum fatalities. It is estimated that over 400,000 infants are delivered to depressed moms in the United States each year. According to the National Institute of Mental Health, postpartum depression can persist for months or even years if not treated.

Related News

Colombian President Petro vows legal action over US drug allegations

Trump cancels Putin meeting, denies US role in Ukraine strikes

Moving the bar forward

Dr. Samantha Meltzer-Brody, director of the Center for Women’s Mood Disorders at the University of North Carolina at Chapel Hill called the approval "a very important step forward," adding that it would be the first rapidly acting antidepressant.

The postpartum period, she continued, was a critical time, and Zuranolone was found to be effective in some trials within three days. 

Catherine Monk, professor and chief of the division of women’s mental health in Obstetrics & Gynecology at Columbia University Vagelos College of Physicians and Surgeons, also praised the approval and "Fast-acting" nature of the drug.

Monk did express concern, however, those with mild or moderate postpartum depression should not immediately resort to the drug, since the medication was tested on those with severe postpartum depression, and psychotherapy should be the first response.

Her view was also shared by Judite Blanc, assistant professor of psychiatry and behavioral sciences at the University of Miami Miller School of Medicine, who explained that Zuranolone “could be particularly beneficial for women who face barriers to accessing long-term treatments, such as low-income women or those with limited healthcare access. However, from a scientific, social, and ethical standpoint, this clinical trial is not the panacea to tackle the maternal health crisis in the U.S. and globally."

She highlighted that “Medications shouldn’t be the first or only line of treatment for mental health conditions, particularly among women, children, and historically oppressed populations."

In addition, Blanc believes there should be more research done among breastfeeding mothers since the trials were mainly conducted on mothers who were not breastfeeding.

She warned that severe depression comes with suicidal ideation and most times a plan to do so. Monk encouraged mothers who feel they need help to seek it.

  • United States
  • FDA
  • Mental Health
  • depression
  • maternity

Most Read

Yemeni Armed Forces Chief of Staff Major General Mohammad Abd al-Karim al-Ghamari , during a ceremony in an undisclosed locations in Yemen, undate (Yemeni Military Media)

Yemeni Armed Forces mourn martyred Chief of Staff al-Ghamari

  • Politics
  • 16 Oct 2025
From previous scenes of the Qassam Brigades targeting an Israeli D9 bulldozer with a Yassin 105 shell, east of Deir al-Balah. (Military Media of the Qassam Brigades)

US knew fatal Rafah blast cause was not Hamas op., says journalist

  • Politics
  • 20 Oct 2025
Smoke and fire rises after 'Israel' launched airstrikes on the village of Ansar, Lebanon, October 16, 2025 (social media)

'Israel' launches two waves of brutal strikes on east, south Lebanon

  • Politics
  • 16 Oct 2025
A woman with her purchased groceries walks out from an underground market, in Beijing, Wednesday, August 6, 2025. (AP Photo/Andy Wong)

Global brands in China face pressure from rising local rivals

  • Economy
  • 17 Oct 2025

Coverage

All
War on Gaza

Read Next

All
Pro-Palestinian activists protest at Lafayette Park across from the White House to mark the approaching one year anniversary of the Israeli war on Gaza, Saturday, October 5, 2024, in Washington. (AP Photo/Jose Luis Magana)
Arts and Culture

Jewish figures calls for sanctions on 'Israel' over Gaza genocide

Activists from the Foreign Press Association during a panel calling for press freedom in Gaza, April 11, 2025 in London, England. (X/ @FPALondon)
Politics

FPA demands Israeli court to allow int'l journalists access to Gaza

Matsapha Correctional Complex is seen in Matsapha, near Mbabane, Eswatini, Thursday July 17, 2025. (AP Photo)
Politics

Cuban man deported from US to Eswatini launches hunger strike

Russia President Vladimir Putin conducts a strategic nuclear forces exercise via videoconference from the Presidential Situation Centre at the Kremlin in Moscow, on Wednesday, October 22, 2025. (Alexander Kazakov, Sputnik, Kremlin Pool Photo via AP)
Politics

Putin oversees ICBM, cruise missile tests in strategic nuclear drill

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS